Capital Readiness · Services
Deep-Tech and Investors: Bridging the Language Gap Between Science and Capital
Deep-tech founders often know more about their technology than any investor they meet. The challenge is translating that depth into a story about risk, value and time.

Deep-tech companies, built on scientific or engineering breakthroughs, face a particular challenge with investors. The technology is hard to evaluate, the path to market is long, and the capital needs are significant. Founders who explain the science brilliantly can still lose investors who cannot see the business.
Speaking the investor’s language
Investors need to understand three things: why the technology matters, what has to happen before it becomes a business, and how their capital moves the company along that path. Technology readiness levels (TRL) and manufacturing readiness levels (MRL) offer a shared language for the second question.
Making the path tangible
- Map the path from today’s technology to a product customers will buy.
- Show which risks are technical, which are commercial and which are operational.
- Explain what each funding stage buys, in evidence rather than activity.
- Identify the partners, customers or grants that reduce the capital needed.
Hardware, software and cyber
- Hardware deep-tech: materials, photonics, semiconductors and robotics require a credible path to manufacturing.
- Software deep-tech: advanced algorithms and AI need proof that they work on real data, at scale.
- Cyber deep-tech: novel security approaches need proof against real threats, and a route through cautious buyers.
How we work
We work with founders to build the bridge between the science and the business case: the roadmap, the readiness assessment, the operating plan and the narrative, and prepare them for technical and operational due diligence.
Questions for the founders
- Can an investor without our background explain our advantage after one meeting?
- What would it take to reach the next readiness level, and what will it cost?
- Which partner could shorten our path to market?
This service is part of our Capital Readiness division. See all Capital Readiness services, or talk to us about your situation.
This article reflects the author’s professional opinion only. It is general information, not professional advice or a recommendation to take any action, and any use of it is the reader’s sole responsibility.
